APA (7th ed.) Citation

Craddock, C., Versluis, J., Labopin, M., Socie, G., Huyn, A., Deconinck, E., . . . Nagler, A. (2016). Characterization of factors determining the kinetics of disease relapse after allogeneic Stem Cell Transplantation (allo-SCT) or chemotherapeutic consolidation for Acute Myeloid Leukaemia (AML) in First CR: A survey from HOVON-SAKK and the acute leukaemia working party of the EBMT. American Society of Hematology.

Chicago Style (17th ed.) Citation

Craddock, C., et al. Characterization of Factors Determining the Kinetics of Disease Relapse After Allogeneic Stem Cell Transplantation (allo-SCT) or Chemotherapeutic Consolidation for Acute Myeloid Leukaemia (AML) in First CR: A Survey from HOVON-SAKK and the Acute Leukaemia Working Party of the EBMT. American Society of Hematology, 2016.

MLA (9th ed.) Citation

Craddock, C., et al. Characterization of Factors Determining the Kinetics of Disease Relapse After Allogeneic Stem Cell Transplantation (allo-SCT) or Chemotherapeutic Consolidation for Acute Myeloid Leukaemia (AML) in First CR: A Survey from HOVON-SAKK and the Acute Leukaemia Working Party of the EBMT. American Society of Hematology, 2016.